SEC Form 4 · accession 0001587221-18-000016
Zosano Pharma Corp · ZSAN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve Elms
Director · 10% Owner
Period of report
May 17, 2018
Accepted (ET)
May 21, 2018 · 8:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001587221
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $4.27 | May 17, 2018 | A | 25,000 | A | — | May 17, 2028 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F125% of the total number of shares underlying the stock option vest on May 17, 2019, and the remaining underlying shares vest in equal monthly installments over the following three-year period.